Teva Contests 2 Of Gilead's Truvada Patents
Israel-based Teva Pharmaceutical Industries Inc. is taking steps to gain regulatory approval to market a generic version of Gilead Sciences Inc.'s lucrative HIV medication Truvada and has challenged two of the...To view the full article, register now.
Already a subscriber? Click here to view full article